Richard Ryan

Bill Nicklin

Edward Jackson

Andy Newby

Dick Ryan

Daniel Bouchin

Ted Jackson

- SOTK reported **record first-half fiscal 2026 revenue of $10,300,000** and **net income of $909,000**, or **$0.06 per share**, marking a **36% year-over-year increase** in net income.  **[0000806172_2181902_2]** **[0000806172_2181902_4]** **[0000806172_2181902_7]** 
- The company is experiencing **strong momentum in the medical device industry**, with second-quarter medical market sales increasing **150% year-over-year to $1,000,000**, which is helping to mitigate an anticipated decline in clean energy orders.  **[0000806172_2181902_2]** **[0000806172_2181902_3]** 
- SOTK has **increased its full fiscal year guidance** to reflect **modest revenue growth**, balancing caution regarding clean energy and tariff policies with growing demand from the medical device industry.  **[0000806172_2181902_2]** **[0000806172_2181902_4]** 
- The company maintains a **strong balance sheet** with a **backlog of $11,200,000** and **$10,600,000 in cash** with **no debt** as of **August 31, 2025**.  **[0000806172_2181902_2]** **[0000806172_2181902_4]** **[0000806172_2181902_7]** 
- Strategic investments in its Forward Deployed Engineering (FDE) model and product line expansion, particularly in the semiconductor market's move to **300 millimeter environments**, are expected to drive future growth and margin expansion.  **[0000806172_2181902_10]** **[0000806172_2181902_11]** **[0000806172_2181902_12]**

SOTK Reports Record First-Half Fiscal 2026 Revenue and Increased Guidance

- Sono-Tek Corporation announced it received a purchase order valued at over **$2.8 million** from a major U.S.-based medical device manufacturer.  **[806172_0001171520-25-000317_ex99-1.htm:0]** 
- The order, placed by an **existing customer** ramping up production, includes multiple advanced ExactaCoat MD (Medical Device) systems with expanded capabilities.  **[806172_0001171520-25-000317_ex99-1.htm:0]** 
- Deliveries of the new equipment are expected to begin in **early 2026** and be completed within the **first half of 2026**.  **[806172_0001171520-25-000317_ex99-1.htm:0]** 
- This order is from a different customer than the **$5 million** medical device order announced last month, further broadening Sono-Tek's high-value opportunities.  **[806172_0001171520-25-000317_ex99-1.htm:0]**

Sono-Tek receives $2.8 million order for medical device coating systems

- Sono-Tek Corporation reported **second quarter fiscal year 2026 net sales of $5.163 million** and a **24% increase in net income to $424 thousand**.  **[806172_164df22e6b7b4b9aa9853d6998d00a9e_0]** **[806172_164df22e6b7b4b9aa9853d6998d00a9e_1]** 
- For the first half of fiscal year 2026, the company achieved **record revenue of $10.30 million** and a **35% increase in net income** to **$909 thousand**.  **[806172_164df22e6b7b4b9aa9853d6998d00a9e_0]** **[806172_164df22e6b7b4b9aa9853d6998d00a9e_5]** 
- Sales in the **Medical market increased by 150%** year-over-year to **$1.00 million** in Q2 FY2026, contributing to a **50% sequential increase in backlog** to **$11.21 million**.  **[806172_164df22e6b7b4b9aa9853d6998d00a9e_0]** **[806172_164df22e6b7b4b9aa9853d6998d00a9e_4]** 
- The company updated its **FY2026 guidance**, anticipating **modest revenue growth** with increasing demand in the medical device market.  **[806172_164df22e6b7b4b9aa9853d6998d00a9e_0]** **[806172_164df22e6b7b4b9aa9853d6998d00a9e_1]**

Sono-Tek Reports Q2 and First Half Fiscal Year 2026 Results

- **Net sales** for Q2 fiscal year 2026 were **$5.163 million**, a slight increase year-over-year, contributing to **record first half fiscal 2026 revenue of $10.30 million**.  **[806172_0001171520-25-000316_ex99-1.htm:0]** **[806172_0001171520-25-000316_ex99-1.htm:1]** **[806172_0001171520-25-000316_ex99-1.htm:2]** 
- **Net income** for Q2 fiscal year 2026 rose **24% to $424 thousand**, or **$0.03 per share**, with first half net income increasing **35% to $909 thousand**, or **$0.06 per share**.  **[806172_0001171520-25-000316_ex99-1.htm:0]** **[806172_0001171520-25-000316_ex99-1.htm:5]** 
- The company's backlog strengthened, increasing **50% sequentially to $11.21 million** by the end of Q2 FY26, driven by new orders from the medical market.  **[806172_0001171520-25-000316_ex99-1.htm:0]** 
- Sales in the **Medical market surged 150% year-over-year to $1.00 million** in Q2 FY26.  **[806172_0001171520-25-000316_ex99-1.htm:0]** **[806172_0001171520-25-000316_ex99-1.htm:2]** 
- Sono-Tek updated its **FY26 guidance**, now projecting **modest revenue growth** for the full fiscal year.  **[806172_0001171520-25-000316_ex99-1.htm:0]**

Sono-Tek Reports Fiscal Second Quarter and First Half 2026 Financial Results

- Sono-Tek Corporation (SOTK) has received a **purchase order valued at over $2.8 million** from a major U.S.-based medical device manufacturer.  **[806172_7083901936d04a5881eb4a95f57bda4b_0]** 
- The order includes multiple **advanced ExactaCoat MD (Medical Device) systems**, with deliveries anticipated to commence in early calendar year 2026 and conclude within the first half of 2026.  **[806172_7083901936d04a5881eb4a95f57bda4b_0]** 
- This order is from a **different customer** than the **$5 million medical device order** announced last month, reinforcing Sono-Tek's strong position and expanding opportunities in the medical device sector.  **[806172_7083901936d04a5881eb4a95f57bda4b_0]**

SONO TEK (SOTK)